The Journal of Diagnostic Imaging in Therapy: A Retrospective Overview
By
Open Access Journal of Diagnostic Imaging in Therapy provides a platform to the unlimited access to scientific articles.
By
Journal of Diagnostic Imaging in Therapy
The Journal of Diagnostic Imaging in Therapy is dedicated to advancing the use of medical imaging in both diagnosis and treatment. It publishes research and clinical insights on X-ray, CT, MRI, ultrasound, and nuclear medicine techniques, highlighting how imaging supports patient management across a range of conditions. The journal features technological developments, applied case studies and discussion of practical and ethical considerations surrounding imaging practice. Sharing peer-informed analysis and clinical experience supports education and professional development among radiologists, clinicians, and imaging scientists. It also encourages collaboration by connecting researchers and practitioners working in related areas. Through critical discussion and evidence-based reporting, the journal contributes to improved standards, innovation and patient-centred care in diagnostic imaging and therapy.
home »
By
Journal of Diagnostic Imaging in Therapy – Author Services
By
Author services provide essential support, ensuring manuscripts meet journal standards, enhancing publication quality, and facilitating peer review.
SPECT/CT activity quantification in 99mTc-MAA acquisitions
Calibration of a SPECT-CT scanner for activity quantification in technetium-99m macroaggregates.
Open letter to journal editors on: international consensus radiochemistry nomenclature guidelines
By
Harmonised nomenclature recommendations for radiopharmaceutical terminology.
Can serial FCH-PET/CT scans predict the response to treatments in castrate resistant prostate cancer?
By
Evaluation of metastatic castrate-resistant prostate cancer using fluorine-18 choline PET-CT imaging.
Target volume definition and dosimetric issues in radiotherapy treatment of head and neck disease with FDG-PET/CT: a monocentric experience
By
The role of FDG-PET/CT in radiotherapy treatment of head and neck diseases.
Nucleoside transporters in PET imaging of proliferating cancer cells using 3ꞌ-deoxy-3ꞌ-[18F]fluoro-L-thymidine
PET probes to investigate the movement of nucleosides across biological membranes.
Squaryl molecular metaphors – application to rational drug design and imaging agents
By
Application of squaryl building blocks towards creative functional group chemistry.
MR-based attenuation correction in brain PET/MR studies: a short review
By
PET/MR scanners used in the area of neurological and psychiatric medicine.
Nuclear neurology: a significant advancement to diagnose brain disorders
By
Nuclear imaging is used to detect the different organs inside a patient’s body.
Synthesis, NMR analysis and applications of isotope-labelled hydantoins
By
Hydantoin is found in pharmacologically active molecules, such as phenytoin.
Solitary increase of 11C-choline uptake in an enchondroma patient with biochemical recurrence of prostate cancer
Enchondroma is a benign bone tumor in the medullary cavity of bone.
Lacrimal scintigraphy in the supine lateral head position
By
Supine side-down eye position inhibits the transfer of the tracer into the lacrimal sac.
Incidence of second cancers in thyroid cancer patients treated with radioactive iodine ablation: how high is really the risk?
By
Differentiated thyroid cancer is a common endocrine tumor with increasing incidence and excellent prognosis.
NMR active nuclei for biological and biomedical applications
By
NMR active nuclei used in biological and biomedical systems and samples.
Editorial review 2016 nuclear medicine, diagnostic imaging and therapy
By
Topics on MRI, ablation, lacrimal scintigraphy and enchondroma.
Editorial review 2015-nuclear medicine, diagnostic imaging and therapy
By
Topics on nano-particles, glucose transporter, nitroimidazole and microsphere therapy.
Basic premises to molecular imaging and radionuclide therapy
By
Overview on the central role of chelation in labelling radiocompounds.
Gallium-68 radiotracers for Alzheimer’s plaque imaging
By
Imaging of β-amyloid plaques are necessary for clinical and neuropsychological characteristics in Alzheimer’s disease.
Nano-aptamer for breast cancer imaging: initial considerations
By
Application of aptamers in drug delivery systems and radiopharmacy.
Reirradiation of spinal metastases using an add-on double-focus micro multileaf collimator and a three partial-arc conformal avoidance technique with optimized beam weights: a planning study
By
The reirradiation of spinal metastases is frequently performed by cyberknife or tomotherapy.
A review of 3D image-based dosimetry, technical considerations and emerging perspectives in 90Y microsphere therapy
Yttrium-90 radioembolization is a well-established therapy for the treatment of hepatocellular carcinoma.
Bifunctional metal-nitroimidazole complexes for hypoxia theranosis in cancer
By
Nitroimidazole (azomycin) is an effective radiosensitizer for hypoxic cells.
Roles of facilitative glucose transporter GLUT1 in [18F]FDG positron emission tomography (PET) imaging of human diseases
The facilitative glucose transport protein GLUT1 has important roles in PET imaging of human diseases.
PET/CT images quantification for diagnostics and radiotherapy applications
By
PET/CT images are used for detecting, staging and monitoring various malignant tumours.
Polymeric nano-hydroxyapatite coated with polylactic acid (PLA): considering new possibilities for radiopharmacy
By
A method uses polylactic acid as the polymer to encapsulate nano-hydroxyapatite.
Inaugural editorial review: nuclear medicine, diagnostic imaging and therapy
By
Topics on PET imaging, automated radiosynthesis, breast cancer, prostate cancer therapy and ultrasound.
18F-Fluoride as a marker of unstable atheroma – a perspective
Fluorine-18 PET imaging marker of atherosclerosis to detect vascular calcification resulting from unstable atheroma.
Update on transcranial sonography applications in movement disorders
By
Diagnostic tool transcranial B-mode sonography of brain parenchyma is used to investigate atypical parkinsonian syndromes.
Choosing a target for targeted radionuclide therapy using biomarkers to personalize treatment
By
Targeted radionuclide therapy potential role in nuclear medicine drawing a parallel to iodide-131 in treatment of thyroid abnormalities.